GSK completes acquisition of 35Pharma, gaining pulmonary hypertension candidate - Manufacturing Chemist
HealthcareAdd-on
GSK→35Pharma
Apr 15, 2026
GSK — Acquisitions & M&A Deals
2 dealsTracking 2 M&A deals by GSK.
GSK to Acquire Rapt for $2.2B, Adding Food Allergy Candidate to Pipeline - Genetic Engineering and Biotechnology News
HealthcareMerger
GSK→Rapt Therapeutics
Jan 20, 2026